申请人:Dhar T.G. Murali
公开号:US20120202802A1
公开(公告)日:2012-08-09
The present application describes modulators of chemokine receptor activity of formula (I) or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using modulators of formula (I) are disclosed.
本申请描述了化学式(I)的趋化因子受体活性调节剂,或其立体异构体或药学上可接受的盐。此外,还公开了使用化学式(I)的调节剂治疗和预防炎症性疾病,如哮喘和过敏性疾病,以及自身免疫病理学,如类风湿性关节炎和移植排斥等的方法。